ID | 390 |
No | 390 |
Brand Name | DOBUTAMINE - HAMELN 12.5 MG/ML INJECTION |
Ingredients | DOBUTAMINE HYDROCHLORIDE 14 MG/ML EQ.TO DOBUTAMINE 12.5 MG/ML |
Dosage Form | SOLUTION FOR INJECTION |
Primary Packaging | AMPOULES |
Storage | DO NOT STORE 25"C |
Shelf Life | 36 MONTHS FROM MANUFACTURING DATE |
Pack Size | BOX OF 5 AMPOULES X 20 ML |
Dispensing Category | Prescription only |
ATC Classification | C01CA07 |
Pharmaceutical Class | DOPAMINERGIC AGENT |
Indications | DOBUTAMINE IS INDICATED FOR PATIENTS WHO REQUIRE A POSITIVE INOTROPIC SUPPORT IN THE TREATMENT OF CARDIAC DECOMPENSATION DUE TO DEPRESSED CONTRACTILITY.IN CARDIOGENIC SHOCK CHARACTERISED BY HEART FAILURE WITH SEVERE HYPOTENSION. |
Contraindications | DOBUTAMINE MUST NOT BE USED IN THE CASE OF :
- KNOWN HYPERSENSITIVITY TO DOBUTAMINE OR TO ANY OF THE EXCIPIENTS |
Side Effects | EVALUATION OF UNDESIRABLE EFFECTS IS BASED ON THE FOLLOWING FREQUENCY SCALE : CARDIOVASCULAR. |
Unit Price | - |
EDL |
Yes |
Description | THE PRODUCT IS A CLEAR, COLOURLESS OR ALMOST COLOURLESS SOLUTION |
Note | |
License Owner | DAOVI PHARMA IMPORT-EXPORT SOLE CO.,LTD |
Manufacturer | SIEGFRIED HAMELN GMBH |
Country | GERMANY |
Import Registration No | 51613.01.00 |
Import Registration Date | 2004-04-23 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2021-08-19 |
FDD Registration No | 11 I 4335/17 |
FDD Registration Date | 2022-05-17 |
Expiry Date | 2025-05-16 |